Another venture capital firm that backs biotechs has raised a multimillion-dollar fund—money the firm, Cambridge, MA-based Atlas Venture, says it will use to continue creating and funding companies that are creating new medicines. Atlas revealed Friday that it closed its 12th fund after raising $400 million, a total that pushes the amount the company has […]